{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:31:27Z","timestamp":1778934687925,"version":"3.51.4"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00533","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T04:18:14Z","timestamp":1536639494000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["The Importance of an Early and Accurate MEN1 Diagnosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Joanne M.","family":"de Laat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"van Leeuwaarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerlof D.","family":"Valk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1590\/S1807-59322007000400014","article-title":"The impact of clinical and genetic screenings on the management of the multiple endocrine neoplasia type 1","volume":"62","author":"Louren\u00e7o","year":"2007","journal-title":"Clinics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/ERC-13-0482","article-title":"Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis","volume":"21","author":"Pieterman","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1055\/s-0031-1286324","article-title":"Clinical and prognostic implications of the genetic diagnosis of hereditary net syndromes in asymptomatic patients","volume":"43","author":"Ramundo","year":"2011","journal-title":"Horm Metab Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"jc.2015-3766","DOI":"10.1210\/jc.2015-3766","article-title":"Impact of delay in diagnosis in outcomes in MEN1: results from the Dutch MEN1 study group","volume":"101","author":"van Leeuwaarde","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"B8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1210\/jc.2013-4491","article-title":"Primary hyperparathyroidism in young people. When should we perform genetic testing for multiple endocrine neoplasia 1 (MEN-1)?","volume":"99","author":"Lassen","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2005.02190.x","article-title":"Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing","volume":"62","author":"Ellard","year":"2005","journal-title":"Clin Endocrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1210\/jc.2007-0476","article-title":"Clinical testing for mutations in the MEN1 gene in Sweden: a report on 200 unrelated cases","volume":"92","author":"Tham","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"key":"B17","doi-asserted-by":"publisher","first-page":"T227","DOI":"10.1530\/ERC-17-0203","article-title":"Management impact: effects on quality of life and prognosis in MEN1","volume":"24","author":"Marini","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"B18","first-page":"158","article-title":"Zur normalen und pathologischen Histologie der Glandula thyreoidea, parathyreoidea und Hypophysis","volume":"33","author":"Erdheim","year":"1903","journal-title":"Beitr Pathol Anat."},{"key":"B19","first-page":"1","article-title":"A case of hypophyseal tumor with associated tumorlike enlargement of the parathyroids and islands of Langerhans","volume":"45","author":"Llyod","year":"1929","journal-title":"Bull Johns Hopkins Hosp."},{"key":"B20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/jcem-13-1-20","article-title":"Multiple endocrine adenomas; report of 8 cases in which the parathyroids, pituitary and pancreatic islets were involved","volume":"13","author":"Underdahl","year":"1953","journal-title":"J Clin Endocrinol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1365-2265.2000.00966.x","article-title":"Clinical features of multiple endocrine neoplasia type 1 ( MENI ) phenocopy without germline MEN7 gene mutations : analysis of 20 Japanese sporadic cases with MEN1","volume":"52","author":"Hai","year":"2000","journal-title":"Clin Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1136\/jmg.40.5.e72","article-title":"Mutational and gross deletion study of the MEN1 gene and correlation with clinical features in Spanish patients","volume":"40","author":"Cebrian","year":"2003","journal-title":"J Med Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2265.2011.04134.x","article-title":"A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype","volume":"75","author":"Raef","year":"2011","journal-title":"Clin Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/BF03345419","article-title":"A novel menin gene deletional mutation in a little series of Italian patients affected by apparently sporadic multiple endocrine neoplasia type 1 syndrome","volume":"35","author":"Giacche","year":"2012","journal-title":"J Endocrinol Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/01.GIM.0000153663.62300.F8","article-title":"Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory","volume":"7","author":"Klein","year":"2005","journal-title":"Genet Med."},{"key":"B27","unstructured":"Recessive transmission of a multiple endocrine neoplasia syndrome in the rat304851\n            FritzA\n            WalchA\n            PiotrowskaK\n            RosemannM\n            Sch\u00e4fferE\n            WeberK\n          12036912Cancer Res.622002"},{"key":"B28","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27(Kip1) cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"E1825","DOI":"10.1002\/humu.21354","article-title":"A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization","volume":"31","author":"Molatore","year":"2010","journal-title":"Hum Mutat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-11-0929","article-title":"Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype","volume":"166","author":"Malanga","year":"2012","journal-title":"Eur J Endocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1003350","DOI":"10.1371\/journal.pgen.1003350","article-title":"A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotype","volume":"9","author":"Occhi","year":"2013","journal-title":"PLoS Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"K7","DOI":"10.1530\/EJE-14-0080","article-title":"A heterozygous frameshift mutation in exon 1 of CDKN1B gene in a patient affected by MEN4 syndrome","volume":"171","author":"Tonelli","year":"2014","journal-title":"Eur J Endocrinol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1210\/jc.2005-2671","article-title":"Clinical characterization of familial isolated pituitary adenomas","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"key":"B37","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1073\/pnas.0700004104","article-title":"Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations","volume":"104","author":"Georgitsi","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B38","first-page":"1","article-title":"AIP -related familial isolated pituitary adenomas","volume":"2","author":"Korbonits","year":"2012","journal-title":"Gene Rev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2265.2008.03379.x","article-title":"Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations","volume":"70","author":"Igreja","year":"2009","journal-title":"Clin Endocrinol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1210\/jc.2006-2563","article-title":"The parathyroid\/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations","volume":"92","author":"Ozawa","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"key":"B41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2265.2008.03363.x","article-title":"Germline mutations in the CDKN1B gene encoding p27 Kip1 are a rare cause of multiple endocrine neoplasia type 1","volume":"70","author":"Owens","year":"2009","journal-title":"Clin Endocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-120-10-199405150-00001","article-title":"Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population","volume":"120","author":"Hall","year":"1994","journal-title":"Ann Intern Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1210\/jc.2018-00259","article-title":"High fear of disease occurrence is associated with low quality of life in patients with Multiple Endocrine Neoplasia type 1 (MEN1): results from the dutch MEN1 study group","volume":"103","author":"van Leeuwaarde","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"B46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/archsurg.141.8.777","article-title":"Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model","volume":"141","author":"Kebebew","year":"2006","journal-title":"Arch Surg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral clearance for primary hyperparathyroidism in selected patients with multiple endocrine neoplasia type 1","volume":"40","author":"Kluijfhout","year":"2016","journal-title":"World J Surg."},{"key":"B49","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"B50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/EJE-12-0210","article-title":"Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors","volume":"167","author":"de Laat","year":"2012","journal-title":"EurJ Endocrinol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the groupe d'\u00e9tude des tumeurs endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1210\/jc.2013-1768","article-title":"Penetrance of functioning and nonfunctioning pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 in the second decade of life","volume":"99","author":"Goncalves","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B54","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome - A prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/cncr.23648","article-title":"Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies","volume":"113","author":"Jensen","year":"2008","journal-title":"Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000443168","article-title":"ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms","volume":"103","author":"Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","article-title":"Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids","volume":"26","author":"Caplin","year":"2015","journal-title":"Ann Oncol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000225948","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: biotherapy","volume":"90","author":"Oberg","year":"2009","journal-title":"Neuroendocrinology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"vii124","DOI":"10.1093\/annonc\/mds295","article-title":"Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Oberg","year":"2012","journal-title":"Ann Oncol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1210\/jc.2004-1155","article-title":"Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series","volume":"90","author":"Ferolla","year":"2005","journal-title":"J ClinEndocrinol Metab."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00268-009-9980-y","article-title":"Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)","volume":"33","author":"Goudet","year":"2009","journal-title":"World J Surg."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1210\/jc.2014-1560","article-title":"Natural course and survival of neuroendocrine tumors of thymus and lung in MEN1 patients","volume":"99","author":"de Laat","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B63","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2265.2012.04467.x","article-title":"Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions","volume":"78","author":"Sakurai","year":"2013","journal-title":"Clin Endocrinol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00423-001-0268-4","article-title":"Clinical and molecular diagnosis of multiple endocrine neoplasia type 1","volume":"386","author":"Karges","year":"2002","journal-title":"Langenbeck's Arch Surg"},{"key":"B65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1136\/jmg.2003.017319","article-title":"A report of a national mutation testing service for the MEN1 gene: clinical presentations and implications for mutation testing","volume":"42","author":"Cardinal","year":"2005","journal-title":"J Med Genet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","article-title":"Osteoporosis in multiple endocrine neoplasia type 1","volume":"134","author":"Burgess","year":"1999","journal-title":"Arch Surg."},{"key":"B67","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1530\/EJE-08-0153","article-title":"Multiple endocrine neoplasia type 1 in Brazil: MEN1 founding mutation, clinical features, and bone mineral density profile","volume":"159","author":"Louren\u00e7o","year":"2008","journal-title":"Eur J Endocrinol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1359\/jbmr.090304","article-title":"Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity","volume":"24","author":"Eller-Vainicher","year":"2009","journal-title":"J Bone Miner Res."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"25","author":"Louren\u00e7o","year":"2010","journal-title":"J Bone Miner Res."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00533\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T04:18:50Z","timestamp":1536639530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00533\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,11]]},"references-count":69,"alternative-id":["10.3389\/fendo.2018.00533"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00533","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,11]]},"article-number":"533"}}